The natural history of cerebral cavernous malformations (CMs) has been widely studied, but the clinical course of untreated thalamic CMs is largely unknown. Hemorrhage of these lesions can be devastating. The authors undertook this study to obtain a prospective hemorrhage rate and provide a better understanding of the prognosis of untreated thalamic CMs.
This longitudinal cohort study included patients with thalamic CMs who were diagnosed between 2000 and 2015. Clinical data were recorded, radiological studies were extensively reviewed, and follow-up evaluations were performed.
A total of 121 patients were included in the study (56.2% female), with a mean follow-up duration of 3.6 years. The overall annual hemorrhage rate (subsequent to the initial presentation) was calculated to be 9.7% based on the occurrence of 42 hemorrhages over 433.1 patient-years. This rate was highest in patients (n = 87) who initially presented with hemorrhage and focal neurological deficits (FNDs) (14.1%) (χ2 = 15.358, p < 0.001), followed by patients (n = 19) with hemorrhage but without FND (4.5%) and patients (n = 15) without hemorrhage regardless of symptoms (1.2%). The initial patient presentations of hemorrhage with FND (hazard ratio [HR] 2.767, 95% CI 1.336–5.731, p = 0.006) and associated developmental venous anomaly (DVA) (HR 2.510, 95% CI 1.275–4.942, p = 0.008) were identified as independent hemorrhage risk factors. The annual hemorrhage rate was significantly higher in patients with hemorrhagic pres entation at diagnosis (11.7%, p = 0.004) or DVA (15.7%, p = 0.002). Compared with the modified Rankin Scale (mRS) score at diagnosis (mean 2.2), the final mRS score (mean 2.0) was improved in 37 patients (30.6%), stable in 59 patients (48.8%), and worse in 25 patients (20.7%). Lesion size (odds ratio [OR] per 0.1 cm increase 3.410, 95% CI 1.272–9.146, p = 0.015) and mRS score at diagnosis (OR per 1 point increase 3.548, 95% CI 1.815–6.937, p < 0.001) were independent adverse risk factors for poor neurological outcome (mRS score ≥ 2). Patients experiencing hemorrhage after the initial ictus (OR per 1 ictus increase 6.923, 95% CI 3.023–15.855, p < 0.001) had a greater chance of worsened neurological status.
This study verified the adverse predictors for hemorrhage and functional outcomes of thalamic CMs and demonstrated an overall annual symptomatic hemorrhage rate of 9.7% after the initial presentation. These findings and the mode of initial presentation are useful for clinicians and patients when selecting an appropriate treatment, although the tertiary referral bias of the series should be taken into account.
Correspondence Da Li, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Tiantan Xili 6, Dongcheng District, Beijing 100050, People's Republic of China. email: email@example.com.
INCLUDE WHEN CITING Published online November 11, 2016; DOI: 10.3171/2016.8.JNS16934.
Drs. Tian, Zheng, and Ma contributed equally to this work.
Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Al-HolouWN, O'LynngerTM, PandeyAS, GemmeteJJ, ThompsonBG, MuraszkoKM, : Natural history and imaging prevalence of cavernous malformations in children and young adults. 9:198–205, 201210.3171/2011.11.PEDS11390)| false
BanksJL, MarottaCA: Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. 38:1091–1096, 20071727276710.1161/01.STR.0000258355.23810.c6)| false
BarkerFGII, Amin-HanjaniS, ButlerWE, LyonsS, OjemannRG, ChapmanPH, : Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. 49:15–25, 200111440436)| false
BertalanffyH, BenesL, MiyazawaT, AlbertiO, SiegelAM, SureU: Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. 25:1–55, 200210.1007/s10143010017911954761)| false
LabaugeP, BrunereauL, LévyC, LabergeS, HouttevilleJP: The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. 42:327–332, 20001087215110.1007/s002340050893)| false
LinFWuJWangLZhaoBTongXJinZ: Surgical treatment of cavernous malformations involving the posterior limb of the internal capsule: utility and predictive value of preoperative diffusion tensor imaging. World Neurosurg88:538–5472016
LinF, WuJ, WangL, ZhaoB, TongX, JinZ, : Surgical treatment of cavernous malformations involving the posterior limb of the internal capsule: utility and predictive value of preoperative diffusion tensor imaging. 88:538–547, 20162656143910.1016/j.wneu.2015.10.074)| false
NikoubashmanODi RoccoFDavagnanamIMankadKZerahMWiesmannM: Prospective hemorrhage rates of cerebral cavernous malformations in children and adolescents based on MRI appearance. AJNR Am J Neuroradiol36:2177–21832015
NikoubashmanO, Di RoccoF, DavagnanamI, MankadK, ZerahM, WiesmannM: Prospective hemorrhage rates of cerebral cavernous malformations in children and adolescents based on MRI appearance. 36:2177–2183, 201510.3174/ajnr.A442726272978)| false
NoteletLChaponFKhourySVahediKChodkiewiczJPCourtheouxP: Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q. J Neurol Neurosurg Psychiatry63:40–451997
NoteletL, ChaponF, KhouryS, VahediK, ChodkiewiczJP, CourtheouxP, : Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q. 63:40–45, 199710.1136/jnnp.63.1.40)| false
PorterPJ, WillinskyRA, HarperW, WallaceMC: Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. 87:190–197, 1997925408110.3171/jns.1997.87.2.0190)| false
PozzatiE, AcciarriN, TognettiF, MarlianiF, GiangasperoF: Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. 38:662–670, 1996869238210.1227/00006123-199604000-00006)| false
ZabramskiJM, WascherTM, SpetzlerRF, JohnsonB, GolfinosJ, DrayerBP, : The natural history of familial cavernous malformations: results of an ongoing study. 80:422–432, 1994811385410.3171/jns.1994.80.3.0422)| false